We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.01B
1-Year Est. Return 47.79%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+47.79%
3 Year Est. Return
+184.24%
5 Year Est. Return
+273.21%
10 Year Est. Return
+1,255.9%
AUM
$2.35B
AUM Growth
+$642M
Cap. Flow
+$723M
Cap. Flow %
30.8%
Top 10 Hldgs %
16.68%
Holding
326
New
175
Increased
123
Reduced
23
Closed
2

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$34.3M
2
CIEN icon
Ciena
CIEN
+$17.7M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$17.5M
4
SBUX icon
Starbucks
SBUX
+$17.5M
5
BMY icon
Bristol-Myers Squibb
BMY
+$15.1M

Sector Composition

Rank Sector Weight
1 Technology 17.09%
2 Healthcare 16.22%
3 Financials 16.19%
4 Industrials 10.08%
5 Consumer Staples 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.9T
$105M 4.46%
3,338,016
+1,073,008
+47% +$34.3M
DIS icon
2
Walt Disney
DIS
$167B
$37.3M 1.59%
327,117
+111,812
+52% +$12.3M
XOM icon
3
ExxonMobil
XOM
$651B
$36.5M 1.55%
438,751
+103,595
+31% +$8.91M
HD icon
4
Home Depot
HD
$332B
$33.6M 1.43%
302,250
+111,920
+59% +$12.5M
MA icon
5
Mastercard
MA
$510B
$33.3M 1.42%
356,230
+160,190
+82% +$14.7M
MSFT icon
6
Microsoft
MSFT
$3.35T
$30.9M 1.32%
700,162
+200,696
+40% +$9.16M
APH icon
7
Amphenol
APH
$197B
$30.4M 1.29%
2,094,768
+752,824
+56% +$10.8M
JPM icon
8
JPMorgan Chase
JPM
$933B
$30.3M 1.29%
446,985
+142,530
+47% +$9.31M
WFC icon
9
Wells Fargo
WFC
$258B
$27.6M 1.17%
490,300
+157,490
+47% +$8.78M
PFE icon
10
Pfizer
PFE
$142B
$27.2M 1.16%
856,415
+207,370
+32% +$6.76M
CVS icon
11
CVS Health
CVS
$134B
$25.4M 1.08%
242,539
+58,476
+32% +$5.97M
PEP icon
12
PepsiCo
PEP
$191B
$25.4M 1.08%
271,854
+110,625
+69% +$10.6M
NXPI icon
13
NXP Semiconductors
NXPI
$61.8B
$25.1M 1.07%
255,403
+20,075
+9% +$2.06M
JNJ icon
14
Johnson & Johnson
JNJ
$617B
$24.7M 1.05%
253,551
+65,520
+35% +$6.56M
FISV
15
Fiserv Inc
FISV
$28.8B
$24.7M 1.05%
595,490
+98,010
+20% +$3.94M
CVX icon
16
Chevron
CVX
$383B
$24.6M 1.05%
255,436
+82,455
+48% +$8.66M
ELV icon
17
Elevance Health
ELV
$81.6B
$23.9M 1.02%
145,301
-5,169
-3% -$826K
CHD icon
18
Church & Dwight Co
CHD
$23.1B
$23.8M 1.01%
586,626
+169,330
+41% +$7.09M
JAH
19
DELISTED
JARDEN CORPORATION
JAH
$23.6M 1.01%
456,078
+63,218
+16% +$3.34M
SWKS icon
20
Skyworks Solutions
SWKS
$9.4B
$23.6M 1%
226,429
-40,435
-15% -$4.09M
DHR icon
21
Danaher
DHR
$138B
$23.4M 1%
406,439
+114,764
+39% +$6.57M
BIIB icon
22
Biogen
BIIB
$30.7B
$23.3M 0.99%
57,648
+1,630
+3% +$654K
GS icon
23
Goldman Sachs
GS
$302B
$23.2M 0.99%
111,176
+31,162
+39% +$6.35M
BA icon
24
Boeing
BA
$175B
$22.8M 0.97%
164,225
+53,383
+48% +$7.79M
C icon
25
Citigroup
C
$222B
$22.6M 0.96%
420,546
+107,971
+35% +$5.87M

Similar funds

Braun Stacey Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Braun Stacey Associates held 326 positions worth $2.35B, up 38% from $1.71B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Braun Stacey Associates deployed $723M of net new capital in Q2 2015, opening 175 new positions and adding to 123 existing holdings. Its largest new stake was Ciena: 776,425 shares worth $18.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Lam Research, an estimated $16.7M trimmed.

  • Braun Stacey Associates's largest Q2 2015 buy was Ciena: 776,425 shares worth $18.4M.
  • Braun Stacey Associates added most to Apple in Q2 2015, an estimated $34.3M increase.
  • Braun Stacey Associates's biggest Q2 2015 reduction was Lam Research, cutting an estimated $16.7M.
  • Braun Stacey Associates fully exited Open Text in Q2 2015, selling an estimated $14.8M.
  • Braun Stacey Associates's ten largest holdings make up 17% of its $2.35B portfolio in Q2 2015.
  • Braun Stacey Associates opened 175 new positions and closed 2 in Q2 2015.
  • Braun Stacey Associates's portfolio value rose 38% quarter-over-quarter to $2.35B.

Based on Braun Stacey Associates's 13F filing for Q2 2015, filed 18 Aug 2015.